𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis

✍ Scribed by Sandra Peternel; Larisa Prpić-Massari; Teo Manestar-Blažić; Ines Brajac; Marija Kaštelan

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
984 KB
Volume
303
Category
Article
ISSN
0340-3696

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ionizing radiation enhances tumor necros
Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells
✍ Takeshi Hori; Takashi Kondo; Masahiko Kanamori; Yoshiaki Tabuchi; Ryohei Ogawa; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB 👁 1 views

## Abstract Despite improvements in chemotherapy and surgery in the treatment of osteosarcoma (OS), satisfactory results are still difficult to achieve. Novel therapeutic modalities need to be developed for osteosarcoma treatment. The combined effects of tumor necrosis factor‐related apoptosis‐indu

Enhancement of TRAIL/Apo2L-mediated apop
Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells
✍ Xiu-Xian Wu; Yoshiyuki Kakehi; Youichi Mizutani; Hiroyuki Nishiyama; Toshiyuki K 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 639 KB

## Abstract Renal cell carcinoma (RCC) is one of the most drug‐resistant malignancies in humans. We show that adriamycin (ADR) and TNF‐related apoptosis‐inducing ligand (TRAIL)/Apo2L have a synergistic cytotoxic effect against RCC cells. This synergistic cytotoxicity was obtained in ACHN, A704, Cak

Naringenin up-regulates the expression o
Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells
✍ Cheng-Yun Jin; Cheol Park; Hye Jin Hwang; Gi-Young Kim; Byung Tae Choi; Wun-Jae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

While TRAIL is relatively non-toxic to normal cells, it can selectively induce apoptosis in many types of transformed cells. Nevertheless, some non-small cell lung cancer (NSCLC) cells are particularly resistant to the effects of TRAIL. Here, we report that in combination with naringenin exposure to